206 related articles for article (PubMed ID: 30343119)
41. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
[TBL] [Abstract][Full Text] [Related]
42. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S
Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487
[TBL] [Abstract][Full Text] [Related]
43. Nanoparticle-Based Vaccines for Brucellosis: Calcium Phosphate Nanoparticles-Adsorbed Antigens Induce Cross Protective Response in Mice.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int J Nanomedicine; 2020; 15():3877-3886. PubMed ID: 32581535
[TBL] [Abstract][Full Text] [Related]
44. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
45. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
46. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.
Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ
Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219
[TBL] [Abstract][Full Text] [Related]
47. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.
Kaushik P; Singh DK; Kumar SV; Tiwari AK; Shukla G; Dayal S; Chaudhuri P
Vet Res Commun; 2010 Feb; 34(2):119-32. PubMed ID: 20013309
[TBL] [Abstract][Full Text] [Related]
48. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
49. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
[TBL] [Abstract][Full Text] [Related]
50. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
51. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.
Cassataro J; Velikovsky CA; Bruno L; Estein SM; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Clin Vaccine Immunol; 2007 Jul; 14(7):869-74. PubMed ID: 17428946
[TBL] [Abstract][Full Text] [Related]
52. A combined DNA vaccine encoding BCSP31, SOD, and L7/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses.
Yu DH; Hu XD; Cai H
DNA Cell Biol; 2007 Jun; 26(6):435-43. PubMed ID: 17570767
[TBL] [Abstract][Full Text] [Related]
53. Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2015 Oct; 33(42):5532-5538. PubMed ID: 26384448
[TBL] [Abstract][Full Text] [Related]
54. Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Wei S; Yang G; Zhang C; Xi L; Zhang J; Cui Y; Hao J; Zhang H; Zhang H
Microb Biotechnol; 2022 Jun; 15(6):1811-1823. PubMed ID: 35166028
[TBL] [Abstract][Full Text] [Related]
55. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of a DNA vaccine encoding Brucella BvrR in BALB/c mice.
Chen B; Liu B; Zhao Z; Wang G
Mol Med Rep; 2019 Feb; 19(2):1302-1308. PubMed ID: 30569140
[TBL] [Abstract][Full Text] [Related]
57. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
58. Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB/c mice.
Riquelme-Neira R; Retamal-Díaz A; Acuña F; Riquelme P; Rivera A; Sáez D; Oñate A
Vaccine; 2013 Aug; 31(36):3663-7. PubMed ID: 23834811
[TBL] [Abstract][Full Text] [Related]
59. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
60. Oral immunization of mice with Omp31-loaded
Abkar M; Fasihi-Ramandi M; Kooshki H; Sahebghadam Lotfi A
Int J Nanomedicine; 2017; 12():8769-8778. PubMed ID: 29263667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
